{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:00:56Z","timestamp":1787061656898,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006314","name":"Biogen Idec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["6873-P-FEL"],"award-info":[{"award-number":["6873-P-FEL"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["ICT 0002"],"award-info":[{"award-number":["ICT 0002"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008440","name":"International Parkinson and Movement Disorder Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001262","name":"National Parkinson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.parkreldis.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T17:11:50Z","timestamp":1557681110000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Defining the spectrum of spasticity-associated involuntary movements"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-8254","authenticated-orcid":false,"given":"Hesham","family":"Abboud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Macaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-393X","authenticated-orcid":false,"given":"Xin Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Knusel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4784-9418","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Bethoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.parkreldis.2019.05.007_bib1","first-page":"827","article-title":"Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification","volume":"1","author":"Sheean","year":"2009","journal-title":"Pharm. Manag. PM R"},{"key":"10.1016\/j.parkreldis.2019.05.007_bib2","doi-asserted-by":"crossref","first-page":"354906","DOI":"10.1155\/2014\/354906","article-title":"Pathophysiology of spasticity: implications for neurorehabilitation","volume":"2014","author":"Trompetto","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.parkreldis.2019.05.007_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/NRE-2008-23304","article-title":"The interrater and intrarater reliability of the Modified Ashworth Scale in the assessment of muscle spasticity: limb and muscle group effect","volume":"23","author":"Ansari","year":"2008","journal-title":"NeuroRehabilitation"},{"issue":"6","key":"10.1016\/j.parkreldis.2019.05.007_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40271-016-0173-0","article-title":"A cross-sectional study of the impact of spasticity on daily activities in multiple sclerosis","volume":"9","author":"Bethoux","year":"2016","journal-title":"Patient"},{"issue":"4","key":"10.1016\/j.parkreldis.2019.05.007_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/09638288.2016.1146351","article-title":"Prevalence, impact and treatment of spasticity in nursing home patients with central nervous system disorders: a cross-sectional study","volume":"39","author":"Meijer","year":"2017","journal-title":"Disabil. Rehabil."},{"issue":"23","key":"10.1016\/j.parkreldis.2019.05.007_bib6","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","article-title":"Intrathecal baclofen for severe spinal spasticity","volume":"320","author":"Penn","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.parkreldis.2019.05.007_bib7","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/archneur.60.12.1772","article-title":"Levetiracetam for phasic spasticity in multiple sclerosis","volume":"60","author":"Hawker","year":"2003","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2019.05.007_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00415-018-8759-1","article-title":"Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy","volume":"265","author":"Dressler","year":"2018","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2019.05.007_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jelekin.2014.05.013","article-title":"Identification and classification of involuntary leg muscle contractions in electromyographic records from individuals with spinal cord injury","volume":"24","author":"Thomas","year":"2014","journal-title":"J. Electromyogr. Kinesiol."},{"key":"10.1016\/j.parkreldis.2019.05.007_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/mdc3.12321","article-title":"Spinal movement disorders in neuromyelitis Optica: an under-recognized phenomenon","volume":"3","author":"Abboud","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2019.05.007_bib11","article-title":"Movement disorders in early multiple sclerosis and related diseases: a prospective observational study","author":"Abboud","year":"2018","journal-title":"Neurol. Clin. Pract."},{"issue":"8","key":"10.1016\/j.parkreldis.2019.05.007_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1474-4422(07)70193-X","article-title":"Spastic movement disorder: impaired reflex function and altered muscle mechanics","volume":"6","author":"Dietz","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.007_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/jnnp.65.5.794","article-title":"Distribution of muscle weakness of central and peripheral origin","volume":"65","author":"Thijs","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2019.05.007_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0035-1571211","article-title":"Update on the use of botulinum toxin therapy for focal and task-specific dystonias","volume":"36","author":"Lungu","year":"2016","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.007_bib15","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1212\/WNL.57.12.2320","article-title":"Paroxysmal dystonia (tonic spasm) in multiple sclerosis","volume":"57","author":"E1","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.007_bib16","series-title":"The Cerebral Control of Movement","author":"Denny-Brown","year":"1966"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T19:15:11Z","timestamp":1762370111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019302287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":16,"alternative-id":["S1353802019302287"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.007","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the spectrum of spasticity-associated involuntary movements","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}